Duality Advisers, LP Bio Techne Corp Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$67.52 - $89.42 $3.52 Million - $4.66 Million	52,087 Added 1225.29%	56,338 $3.83 Million
Q2 2023 Jul 31, 2023	SELL	$73.76 - $85.98 $2.73 Million - $3.18 Million	-36,969 Reduced 89.69%	4,251 $347,000
Q1 2023 Jun 27, 2023	BUY	$71.62 - $86.62 $1.96 Million - $2.37 Million	27,347 Added 197.12%	41,220 $3.06 Million
Q4 2022 Feb 07, 2023	SELL	$80.67 - $352.29 $247,011 - $1.08 Million	-3,062 Reduced 18.08%	13,873 $1.15 Million
Q3 2022 Nov 03, 2022	BUY	$282.54 - $391.85 $1.95 Million - $2.71 Million	6,915 Added 69.01%	16,935 $4.81 Million
Q2 2022 Aug 08, 2022	BUY	$322.67 - $449.65 $3.23 Million - $4.51 Million	10,020 New	10,020 $3.47 Million

600

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.85B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.